Evidence map›Paper›PMID 32575510›Full record

ArticleBiomolecules2020

Anti-Inflammatory and Chondroprotective Effects of Vanillic Acid and Epimedin C in Human Osteoarthritic Chondrocytes.

Reihane Ziadlou, Andrea Barbero, Ivan Martin, Xinluan Wang, Ling Qin, Mauro Alini, Sibylle Grad

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Pharmacokinetics of seven major components in AβJournal of natural medicines · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Reihane ZiadlouAO Research Institute Davos, 7270 Davos Platz, Switzerland.ORCID 0000-0001-7016-6725
Andrea BarberoDepartment of Biomedicine, University Hospital Basel, University of Basel, 4001 Basel, Switzerland.
Ivan MartinDepartment of Biomedical Engineering, University of Basel, 4123 Allschwil, Switzerland.
Xinluan WangTranslational Medicine R&D Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, China.
Ling QinTranslational Medicine R&D Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518057, China.
Mauro AliniAO Research Institute Davos, 7270 Davos Platz, Switzerland.
Sibylle GradAO Research Institute Davos, 7270 Davos Platz, Switzerland.ORCID 0000-0001-9552-3653
University of Basel · CHAO Foundation · CHChinese Academy of Sciences · CNChinese University of Hong Kong · HK

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 156362
6 · The paper itself

Abstract

In osteoarthritis (OA), inhibition of excessively expressed pro-inflammatory cytokines in the OA joint and increasing the anabolism for cartilage regeneration are necessary. In this ex-vivo study, we used an inflammatory model of human OA chondrocytes microtissues, consisting of treatment with cytokines (interleukin 1β (IL-1β)/tumor necrosis factor α (TNF-α)) with or without supplementation of six herbal compounds with previously identified chondroprotective effect. The compounds were assessed for their capacity to modulate the key catabolic and anabolic factors using several molecular analyses. We selectively investigated the mechanism of action of the two most potent compounds Vanillic acid (VA) and Epimedin C (Epi C). After identification of the anti-inflammatory and anabolic properties of VA and Epi C, the Ingenuity Pathway Analysis showed that in both treatment groups, osteoarthritic signaling pathways were inhibited. In the treatment group with VA, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling was inhibited by attenuation of the nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκBα) phosphorylation. Epi C showed a significant anabolic effect by increasing the expression of collagenous and non-collagenous matrix proteins. In conclusion, VA, through inhibition of phosphorylation in NF-κB signaling pathway and Epi C, by increasing the expression of extracellular matrix components, showed significant anti-inflammatory and anabolic properties and might be potentially used in combination to treat or prevent joint OA.

Indexed as

AgedAged, 80 and overAnabolic AgentsAnti-Inflammatory Agents, Non-SteroidalChondrocytesFemaleFlavonoidsHumansMiddle AgedNF-kappa BOsteoarthritisVanillic AcidAnabolic AgentsAnti-Inflammatory Agents, Non-Steroidalepimedin CFlavonoidsNF-kappa BVanillic Acidanabolicanti-catabolicanti-inflammatory effectsEpimedin CNF-κB signaling pathwayosteoarthritisvanillic acid

Identifiers

PMID32575510
PMCPMC7356262
OpenAlexW3036913614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.